In addition to influencing protein synthesis, degeneration of PRs, which is the ultimate consequence of sustained ER-stress and a key hallmark of IRDs, can also been seen as a therapeutic target. This evidence concerns the gene WNK3 and respiratory distress syndrome in premature infants.